TI
VXRT

tru Independence’s Vaxart VXRT Stock Holding History

tru Independence’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21,752
Closed -$162K – 332
2021
Q2 		$162K Hold
21,752
– – 0.05% 96
2021
Q1 		$190K Buy
21,752
+9,000
+71% +$69.2K 0.04% 245
2020
Q4 		$72.8K Buy
+12,752
New +$81.1K 0.13% 62
2020
Q3 		– Sell
-1,912
Closed -$17 – 848
2020
Q2 		$17 Buy
1,912
+1,908
+47,700% +$5.48K ﹤0.01% 528
2020
Q1 		$0 Hold
4
– – ﹤0.01% 934
2019
Q4 		$0 Buy
+4
New +$1 ﹤0.01% 949

Other funds holding VXRT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

tru Independence's VXRT Position: Q3 2021 in Review

tru Independence sold out of Vaxart (VXRT) in Q3 2021, closing a stake of 21,752 shares — an estimated $162K sold.

tru Independence first reported a position in VXRT in Q4 2019 and held it in 6 quarters. The position peaked at $190K in Q1 2021. 141 funds tracked by Wall St. Rank hold VXRT as of Q3 2021.

  • tru Independence reported no remaining Vaxart position as of Q3 2021 after selling out during the quarter.
  • tru Independence sold 21,752 Vaxart shares in Q3 2021, an estimated $162K.
  • tru Independence first reported a position in Vaxart in Q4 2019 and held it in 6 quarters.
  • tru Independence's Vaxart position peaked at $190K in Q1 2021.
  • 141 funds tracked by Wall St. Rank held Vaxart as of Q3 2021.

Based on tru Independence's 13F filing for Q3 2021, filed 12 Nov 2021.